Judy E. Garber

2.5k citations
8 papers · 1.2k indexed · h-index 6
Topics
BRCA gene mutations in cancer (7 papers)Breast Cancer Treatment Studies (2 papers)Prenatal Screening and Diagnostics (2 papers)

In The Last Decade

Judy E. Garber

7 papers receiving 1.2k citations

Peers

Judy E. Garber
Comparison fields: 5 of 58
  • Genetics 760
  • Oncology 409
  • Molecular Biology 357
  • Reproductive Medicine 318
  • Cancer Research 286
Replace H. T. Lynch with:
H. T. Lynch United States
Lars A. Akslen Norway
Peggy Conrad United States
Theo A.M. van Os Netherlands
Scott M. Weissman United States
J. J. Mulvihill United States
S. Seal United Kingdom
Riccardo Roagna Italy
Rachel Pearlman United States
Leora Witkowski Canada
Judy E. Garber relative to H. T. Lynch United States H. T. Lynch's profile →
Citations per field
00.5×1.5×2.2×
H. T. Lynch · 1×
Citations per year

Countries citing papers authored by Judy E. Garber

Since Specialization
Citations

This map shows the geographic impact of Judy E. Garber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy E. Garber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy E. Garber more than expected).

Fields of papers citing papers by Judy E. Garber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy E. Garber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy E. Garber. The network helps show where Judy E. Garber may publish in the future.

Co-authorship network of co-authors of Judy E. Garber

This figure shows the co-authorship network connecting the top 25 collaborators of Judy E. Garber. A scholar is included among the top collaborators of Judy E. Garber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy E. Garber. Judy E. Garber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 67
3 216
4 1
5 275
6 197
7 102
8 374

About Judy E. Garber

Judy E. Garber is a scholar working on Genetics, Cancer Research and Reproductive Medicine, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (7 papers), Breast Cancer Treatment Studies (2 papers) and Prenatal Screening and Diagnostics (2 papers). The work is most often cited by research in Reproductive Medicine (318 citations), Genetics (760 citations) and Cancer Research (286 citations). Judy E. Garber has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Frederick P. Li, Michie Hisada, Joseph F. Fraumeni, Claire Y. Fung, Barbara Weber, Mary B. Daly, Henry T. Lynch, Susan L. Neuhausen, Timothy R. Rebbeck and Olufunmilayo I. Olopade. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026